Executive Summary
The suit was filed by Glaxo Group Limited seeking rendition of accounts and recovery of money against Glenmark Pharmaceuticals Limited concerning Patent No. IN212714. The parties subsequently reached an amicable settlement, which the Court accepted and decreed the suit in terms of that agreement.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Glaxo Group Limited vs Glenmark Pharmaceuticals Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Apex Laboratories Pvt. Ltd.vsApex Formulations Pvt. Ltd.
The Madras High Court addressed an application seeking a stay in a trademark infringement suit. While the applicant argued for a stay pending opposition proceedings, the court determined that since the original suit was filed under the older Trade and Merchandise Marks Act, 1958, the relevant provisions applied. The court framed an issue questioning the validity of the plaintiff's trade mark registration and adjourned the case to allow the defendant time to comply with statutory requirements regarding challenging the trademark's validity.
M/S Star Syringe LtdvsM/S Tiger Surgical Disposable Pvt Ltd
The plaintiffs allege that the defendants have infringed their patent and seek damages. The case is ongoing with preliminary objections raised by the defendants regarding maintainability due to insolvency proceedings.
Vidya Mandir Classes Ltd.vsWefrew Educations P. Ltd.
The Delhi High Court granted an interim injunction in favor of Vidya Mandir Classes Ltd. against Wefrew Educations P. Ltd., finding that Vidya Mandir had a prima facie case regarding the unauthorized use of its trademarks and proprietary course materials. The court observed that Wefrew was allegedly using these assets while simultaneously claiming disassociation, causing potential irreparable harm to the petitioner. Consequently, Wefrew was immediately restrained from using any material or marks associated with Vidya Mandir Classes.
Alimentary Health LimitedvsController Of Patents And Designs
Alimentary Health Limited appealed the refusal of its Indian Patent Application (No. 3989/DELNP/2012), which covered a formulation using the probiotic strain Bifidobacterium longum NCIMB 41676 (AH1714). The Controller had rejected the application, citing lack of inventive step and non-patentability under various sections of the Patent Act. The Delhi High Court set aside this refusal order and remanded the matter for fresh consideration. The court provided detailed directions to the Controller, requiring a thorough reassessment focusing on novelty, specific dosage/methodology, and whether the claims relate to second medical use.
Emd Millipore CorporationvsAssistant Controller Of Patents And Designs
Emd Millipore Corporation appealed an order dated January 19, 2024, where its patent application (No. 201614010107) for 'Enhanced Aerosol Test for Assessing Filter Integrity' was refused by the Assistant Controller of Patents and Designs due to lack of inventive step. The court issued notice and set a date for further hearing.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.